Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ONC
1951
BeOne Medicines Ltd
ONC
$40.5B
| $6.03M | ﹤0.01% |
24,903
-17,843
| -42% | -$4.38M |
2016 Q4
34 quarters
|
|
1952
Grocery Outlet
GO
$1.15B
| $6.03M | ﹤0.01% |
485,230
+124,616
| +35% | +$1.77M |
2019 Q3
23 quarters
|
|
1953
Oceaneering
OII
$4.41B
| $6.03M | ﹤0.01% |
290,850
+49,029
| +20% | +$945K |
2013 Q2
48 quarters
|
|
1954
Agios Pharmaceuticals
AGIO
$1.9B
| $6.01M | ﹤0.01% |
180,704
+67,551
| +60% | +$2.05M |
2013 Q3
47 quarters
|
|
1955
Cactus
WHD
$4.42B
| $6.01M | ﹤0.01% |
137,453
+43,555
| +46% | +$1.82M |
2018 Q1
29 quarters
|
|
1956
Atmus Filtration Technologies
ATMU
$3.73B
| $5.99M | ﹤0.01% |
164,410
+48,642
| +42% | +$1.74M |
2023 Q3
7 quarters
|
|
1957
AXIS Capital
AXS
$6.92B
| $5.97M | ﹤0.01% |
57,541
+10,923
| +23% | +$1.09M |
2013 Q4
46 quarters
|
|
1958
Denali Therapeutics
DNLI
$3.2B
| $5.96M | ﹤0.01% |
425,981
+185,333
| +77% | +$2.61M |
2019 Q1
25 quarters
|
|
1959
Huntsman Corp
HUN
$1.5B
| $5.94M | ﹤0.01% |
570,087
-109,583
| -16% | -$1.34M |
2013 Q2
48 quarters
|
|
1960
Hilton Grand Vacations
HGV
$2.71B
| $5.93M | ﹤0.01% |
142,849
-303,706
| -68% | -$11.5M |
2022 Q1
13 quarters
|
|
1961
PUT
TransDigm Group
TDG
$60.3B
| $5.93M | ﹤0.01% |
3,900
-8,600
| -69% | -$12.1M |
2024 Q4
2 quarters
|
|
1962
Polaris
PII
$3.06B
| $5.93M | ﹤0.01% |
145,870
+76,116
| +109% | +$2.87M |
2013 Q2
48 quarters
|
|
1963
nVent Electric
NVT
$27.4B
| $5.92M | ﹤0.01% |
80,869
-163,152
| -67% | -$10M |
2018 Q2
28 quarters
|
|
1964
CorVel
CRVL
$3.81B
| $5.91M | ﹤0.01% |
57,465
+20,974
| +57% | +$2.31M |
2013 Q2
48 quarters
|
|
1965
Recursion Pharmaceuticals
RXRX
$2.21B
| $5.89M | ﹤0.01% |
1,164,689
+573,683
| +97% | +$2.82M |
2022 Q1
13 quarters
|
|
1966
Arrow Electronics
ARW
$12.3B
| $5.89M | ﹤0.01% |
46,199
-35,530
| -43% | -$4.08M |
2013 Q2
48 quarters
|
|
1967
Bread Financial
BFH
$3.77B
| $5.88M | ﹤0.01% |
102,872
+38,320
| +59% | +$1.93M |
2013 Q2
48 quarters
|
|
1968
IAMGOLD
IAG
$10.6B
| $5.84M | ﹤0.01% |
795,073
+366,144
| +85% | +$2.57M |
2013 Q2
48 quarters
|
|
1969
CALL
IBM
IBM
$210B
| $5.84M | ﹤0.01% |
19,800
-2,230,200
| -99% | -$575M |
2022 Q4
10 quarters
|
|
1970
PUT
Genuine Parts
GPC
$17.5B
| $5.84M | ﹤0.01% |
+48,100
| New | +$5.79M |
2025 Q2
0 quarters
|
|
1971
NextNav
NN
$2.36B
| $5.83M | ﹤0.01% |
383,876
+107,834
| +39% | +$1.38M |
2022 Q1
13 quarters
|
|
1972
Agilysys
AGYS
$2.8B
| $5.83M | ﹤0.01% |
50,860
+20,193
| +66% | +$1.82M |
2016 Q1
37 quarters
|
|
|
1973
Berkshire Hathaway Class A
BRK.A
$1.08T
| $5.83M | ﹤0.01% |
8
| – | – |
2013 Q2
48 quarters
|
|
1974
Shoals Technologies Group
SHLS
$1.4B
| $5.83M | ﹤0.01% |
1,371,643
+1,144,871
| +505% | +$4.98M |
2022 Q1
13 quarters
|
|
|
SNDK
1975
CALL
Sandisk
SNDK
$252B
| $5.83M | ﹤0.01% |
128,500
| – | – |
2025 Q1
1 quarter
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.